Navigation Links
European Medicines Agency accepts marketing authorization application for Boehringer Ingelheim and Eli Lilly and Company's empagliflozin*, an investigational type 2 diabetes treatment
Date:3/26/2013

RIDGEFIELD, Conn. and INDIANAPOLIS, March 26, 2013 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced the European Medicines Agency (EMA) has accepted for review a marketing authorization application (MAA) for the investigational sodium glucose co-transporter-2 (SGLT2) inhibitor empagliflozin*, for the treatment of type 2 diabetes mellitus (T2D) in adults. The acceptance of the MAA marks the beginning of the review process in the European Union for this potential oral diabetes treatment.

"We are pleased the EMA has accepted our marketing authorization application for a potential new treatment option to help patients better manage their type 2 diabetes mellitus," said Prof. Klaus Dugi, Corporate Senior Vice President Medicine, Boehringer Ingelheim. "More than 300 million people worldwide live with type 2 diabetes mellitus and varied approaches to treating this condition are needed to help these patients better manage their condition."

A New Drug Application for empagliflozin was recently submitted to the Food and Drug Administration (FDA) in the United States for the treatment of T2D in adults.

Empagliflozin is a member of the SGLT2 inhibitor class of drugs being investigated for the reduction of blood glucose levels in adults with T2D. The emerging SGLT2 inhibitor class removes excess glucose through the urine by blocking glucose re-absorption in the kidney.

About Diabetes

Approximately 25.8 million Americans[1] and an estimated 371 million people worldwide[2] have type 1 or type 2 diabetes. T2D is the most common type, accounting for an estimated 90 percent of all diabetes cases.[2] Diabetes is a chronic disease that occurs when the body either does not properly produce, or use, the hormone insulin.[3] Diabetes
'/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genalyte Announces CE Mark For Maverick(TM) Detection System And Signs On First European Distributors
2. European Commission Designates MST-188 As An Orphan Medicinal Product
3. Baxter And Halozyme Announce Positive Opinion For HyQvia For Treatment Of Primary And Secondary Immunodeficiencies In The European Union
4. Surveyed U.S. and European Neurologists Agree that a Therapys Effect on Physical Disability is the Most Important Attribute Influencing Prescribing Decisions in Secondary-Progressive Multiple Sclerosis
5. SonaCare Medical to Introduce Two New HIFU Products at the European Association of Urology (EAU) Congress
6. European Hearing Aids and Audiology Devices Market
7. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
8. Product Differentiation to Boost European Human Growth Hormones Market, Says Frost & Sullivan
9. BioElectronics Expands European Distribution to Malta
10. Heptares to Present at the 6th Annual European Life Sciences CEO Forum (5-6 March)
11. Cardica Updates Enrollment Progress In European Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... DUBLIN , Aug. 29, 2014 ... the "China Orthopedic Instrument Industry Report, 2014-2017" ... accelerated aging population and rising proportion of reimbursement for ... been effectively released, with its scale presenting a CAGR ... joint products are three product segments of orthopedic instruments ...
(Date:8/29/2014)... Research and Markets  has announced the addition of the ... their offering. The Central Nervous System (CNS) ... of pharmaceuticals industry. The numbers of CNS disorders have increased ... to meet the market requirements. There has been steady to ... the past two decades. The market for CNS therapies is ...
(Date:8/29/2014)... DENVER , Aug. 29, 2014 Does your ... date, nearly 800 doctors have recommended marijuana to the over ... Amendment 20. But the majority of the other roughly 20,300+ ... still know very little about it – even though a ... adults say they have tried it. ...
Breaking Medicine Technology:China Orthopedic Instrument Industry Report, 2014-2017 2US CNS Disorders Drug Pipeline Insight 2014 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4
... 2012 OPKO Health, Inc. and ChromaDex Corporation (OTCBB: ... alliance pursuant to which ChromaDex has licensed to OPKO ... technologies for distribution and business development throughout all of ... BluScience™ ( www.bluscience.com ), ChromaDex,s recently launched ...
... 2012 Uroplasty, Inc. (NASDAQ: UPI ), ... innovative proprietary products to treat voiding dysfunctions, today announced ... study in the United Kingdom. This large ... up to 20 centers across the UK. Using Uroplasty,s ...
Cached Medicine Technology:OPKO Health, Inc. Invests in ChromaDex® Corp. 2OPKO Health, Inc. Invests in ChromaDex® Corp. 3OPKO Health, Inc. Invests in ChromaDex® Corp. 4OPKO Health, Inc. Invests in ChromaDex® Corp. 5Uroplasty Announces Enrollment of First Patients in the CONFIDeNT Clinical Study for Treatment of Fecal Incontinence with Urgent® PC 2Uroplasty Announces Enrollment of First Patients in the CONFIDeNT Clinical Study for Treatment of Fecal Incontinence with Urgent® PC 3
(Date:8/29/2014)... US Preventive Services Task Force recommendations for screening and ... may be ameliorated through technological approaches according to a ... published online August 21, 2014 in the Journal ... David Levine, MD, MA, a third year resident in ... colleagues found that compared to usual care, technology-assisted interventions ...
(Date:8/29/2014)... 29, 2014 According to the ... accepting applications next month for medical marijuana, regulators, ... accepting marijuana as a legalized medicine. New marijuana ... be permitted to operate in accordance with local ... best suited to handle legal cannabis. , ...
(Date:8/29/2014)... The microbiology testing sector is one of the ... is also the hugest challenge facing suppliers during these ... of AIDS – still the world’s key health threat ... opportunistic infections (OIs); bioterrorism threat; advancements in technologies for ... Although for certain infections the etiology remains a mystery, ...
(Date:8/29/2014)... 2014 Floors of hospitals and other ... socks. Also, many patients are relegated to lying down ... recovery, Alzheimer’s, etc. Two inventors from Perrysburg, Ohio, have ... safety. , This special pair of socks helps prevent ... patients who are relegated to beds or chairs from ...
(Date:8/29/2014)... 2014 The 8th Annual Paint Columbus Pink® ... a Cause, Pink Pooch Contest, Light of Life Ceremony, Power ... Pink Bow Campaign – all in support of cancer awareness. ... this year…. Paint Columbus Pink Foam and Obstacle Challenge on ... 727 54th Street, Columbus, Georgia 31904. It will be the ...
Breaking Medicine News(10 mins):Health News:Options for weight loss your primary care doctor might not know about 2Health News:Medical Marijuana Approaches Legalization in Chicago 2Health News:Infectious Disease Testing Universe Examined in New VPG Research Report Available at MarketPublishers.com 2Health News:Infectious Disease Testing Universe Examined in New VPG Research Report Available at MarketPublishers.com 3Health News:Paint Columbus Pink Cancer Awareness/Kick-Off Meeting for Anyone Interested in Participating 2
... too much strain on or weaken children,s immune systems ... from the Robert Koch Institute investigate exactly this research ... International (Dtsch Arztebl Int 2011; 108(7): 105-11). Their ... Health Interview and Examination Survey for Children and Adolescents ...
... the early data from Understanding Society based on 14,000 UK ... people with higher levels of education and by married people. ... on sleep, with those in routine occupations reporting worse sleep ... at the University of Surrey who analysed the findings said: ...
... , THURSDAY, March 3 (HealthDay News) -- More than ... a night, which affects their concentration and general health, ... work performance and the ability to drive safely, found ... Prevention (CDC), which published two sleep studies March 4 ...
... combined effects of chemotherapy and endocrine therapy may increase ... In a study scheduled for publication in the April ... Rehabilitation , researchers from the Oregon Health & Science ... survivors whether they had fallen in the past year ...
... , THURSDAY, March 3 (HealthDay News) -- An analysis ... women with breast cancer, a new study reports. Researchers ... breast cancer tumors, and found that the way collagen fibers ... may aid in a patient,s diagnosis and help determine treatment. ...
... , THURSDAY, March 3 (HealthDay News) -- New ... improved sleep treatments, a new study suggests. A team ... as the emblem of wakefulness persists in a hidden form ... -- something that appears to affect people,s vulnerability to being ...
Cached Medicine News:Health News:The better off sleep better 2Health News:1 in 3 Americans Gets Less Than 7 Hours of Sleep: CDC 2Health News:1 in 3 Americans Gets Less Than 7 Hours of Sleep: CDC 3Health News:Breast cancer survivors at higher risk for falls 2Health News:Tissue Analysis May Help Predict Breast Cancer Outcome 2Health News:Particular Brain Rhythm in Sleep Makes You More Vulnerable to Disturbances 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: